TORONTO, April 23, 2018 -- Grenville Strategic Royalty Corp. (TSXV:GRC) ("Grenville" or the "Company") today announced changes to its senior management team.
Robb McLarty, currently a Managing Director of the Company, has been promoted to Chief Investment Officer and Acting Chief Executive Officer of the Company. Robb has worked with and invested in emerging growth companies for over twenty years. His venture capital investments have delivered top-quartile returns relative to benchmarks.
Steve Parry will be assuming an advisory role with the Company, and will be resigning from the board of directors.
"Steve was a co-founder of the Company and led it through several transitions to bring it to where it is today. He worked tirelessly to find and secure solid investments and consistently added value through his advice and guidance to the investee companies. In addition to advising Grenville, Steve is planning to spend time working directly with some of our existing portfolio companies. We want to thank Steve for his many contributions to the Company", said Catherine McLeod-Seltzer, Chairman of the Company.
"Robb has demonstrated a keen eye and very good investing discipline in sourcing and closing investments for Grenville. Being based in California enables him to access differentiated US-based companies that strengthen the portfolio. We look forward to Robb continuing to add value in an expanded capacity as Chief Investment Officer", continued Ms. McLeod-Seltzer.
Boardwalktech, Inc.
Grenville wishes to congratulate Boardwalktech, Inc. ("Boardwalktech"), an investee company of Grenville, on the completion of its subscription receipt financing for aggregate gross proceeds of approximately CDN$10 million and its proposed reverse takeover transaction (the "Boardwalktech RTO") with Wood Composite Technologies Inc. ("Wood Composite"). For further details regarding these transactions, please see the press releases issued by Wood Composite on April, 2018.
Grenville has been granted the right, in connection with consulting services provided by Grenville to Boardwalktech but subject to the completion of the Boardwalktech RTO, to earn up to 399,424 common share purchase warrants of Boardwalktech at an exercise price of USD$1.67 per share. If granted, these warrants would automatically convert into common share purchase warrants of the resulting issuer upon completion of the Boardwalktech RTO. If the Boardwalktech RTO is not completed, no warrants will be issued to Grenville.
About Grenville
Based in Toronto, Grenville Strategic Royalty Corp. makes growth-oriented investments in established businesses with revenues of up to $50 million. Grenville generates revenues from royalty payments, buyouts from contracts and equity returns. The non-dilutive royalty financing structure offered by Grenville competes directly with traditional equity to meet the long-term financing needs of companies on more attractive commercial terms.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Grenville Strategic Royalty Corp.:
Donnacha Rahill
Chief Financial Officer
Tel: 416-477-2601


Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 



